Key points are not available for this paper at this time.
Complement 3 glomerulopathy (C3G) is a rare kidney disease, with an estimated worldwide incidence of 1-2 million people/year. C3G is associated with a high risk of disease progression, with an estimated 50% of patients progressing to kidney failure within 10 years of diagnosis. Kidney transplant is an option for patients whose native kidney fails. We aimed to understand the prevalence and outcomes of kidney transplant in a real-world study across 8 countries.
Lafayette et al. (Mon,) studied this question.